Literature DB >> 30332892

Novel and emerging innate immune therapeutic targets for pancreatic cancer.

Liang Wang1, Imad Shureiqi2, John R Stroehlein1,3, Daoyan Wei1.   

Abstract

Entities:  

Keywords:  Innate immune; STING; agonist; cyclic GMP-AMP synthase (cGAS); cyclic dinucleotides (CDNs); immune therapy; pancreatic cancer

Mesh：

Year:  2018        PMID： 30332892     DOI： 10.1080/14728222.2018.1538361

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  2 in total

Review 1.  Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment.

Authors:  Chen Chen; Yanlong Liu; Binbin Cui
Journal:  Hum Vaccin Immunother       Date:  2021-01-11       Impact factor: 3.452

2.  TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway.

Authors:  Hongchao Han; Zhilin Zhan; Jie Xu; Zhenshun Song
Journal:  Onco Targets Ther       Date:  2019-12-23       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.